All News

Mike Hennessy, Sr., Chairman and CEO, discusses psychosocial issues associated with women's cancers — the mental, emotional, social and spiritual effects of cancer that occur at diagnosis, during treatment and throughout life after the disease.

Family and friends receive the cancer diagnosis right along with the patient. People change, relationships change and life as you know it may never be the same.

We all have our angels here on earth, but need to know where to find them (and be one) on our difficult cancer journey.

Enormous progress has been made in breast cancer, yet many challenges remain, according to Ann H. Partridge, M.D., MPH.

Administration of Opdivo (nivolumab) before surgical resection in patients with glioblastoma appeared safe and feasible, according to phase 2 trial results published in Nature Medicine.

There is still work to do in the field of molecular diagnosis for renal cell carcinoma, according to David I. Quinn, MBBS, Ph.D., FRACP, FACP.

In metastatic breast cancer, the brain MRI is often a special request for what you don't want but truly need.

Making the shift from survivor to 'thriver' is challenging. In this post, learn how one survivor makes the change.

The Food and Drug Administration (FDA) Expanded Access program appeared to have broad use, involved a wide variety of patients and drugs, and derived clinical benefit, according to an initial summary published in JAMA Oncology.

This cancer survivor finds a hidden treasure in death and dying.

Debu Tripathy, M.D., the editor in chief of CURE®, recently sat down at the Miami Breast Cancer Conference to discuss the importance of oncology nurses in breast cancer care and offered insight as to how they can keep up-to-date with the constant advancements in the field.

From fertility research developments for childhood cancer to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.

Many children with cancer participate in clinical trials. Perhaps little children should be leading us more often in health care?

How being treated for an allergy to cats and persistence finally led to my diagnoses of Hodgkin's lymphoma.

"We hope these thoughts on the prevention of, and awareness about, GI cancers and their side effects will be helpful to patients, survivors and caregivers alike," says CEO and Chairman Mike Hennessy, Sr.

Did we bring this scary, painful, financially draining monster into our lives by eating too many cookies and not doing enough jumping jacks? We need a reliable diagnostic screening tool for ovarian cancer and we need it now.

Surprise! You can’t believe everything you read on the internet!

Adam Brufsky, M.D., Ph.D. discussed treatments for BRCA-positive breast cancer at the 2019 Miami Breast Cancer Conference.

"How worried 'should' I be?", ponders one cancer survivor.

Lenvima (lenvatinib) in combination with weekly paclitaxel induced activity among those with recurrent endometrial and platinum-resistant epithelial ovarian cancer, according to results from a phase I study.

A hospital whose mission is to cure children’s catastrophic diseases is not only providing treatment, but also conducting research and making new medicines. Now, in addition to improving its patient-care and research capabilities, it plans to reach into low-income countries to help cure more children with cancer.

Anemia is so intertwined with cancer that every current patient and survivor should know about it.

During the 2019 Miami Breast Cancer Conference, an expert discussed financial toxicity and the role of healthcare providers in addressing the cost of care with their patients.

Fourth-generation, family-owned egg and feed farm joins local cycling event to achieve Victory Over Cancer®.

Treatment with the combination of Keytruda (pembrolizumab), Avastin (bevacizumab) and metronomic cyclophosphamide appeared safe and effective in women with recurrent epithelial ovarian cancer, according to results from an open-label phase 2 study.

How to build good self-care habits for a better life with cancer.